| Name | Title | Contact Details |
|---|---|---|
Andrew Sherman |
Senior Director and Deputy Security Officer | Profile |
Darius Felton |
Chief Medical Information Officer - H H/Coney Island | Profile |
Kevin Lynch |
Senior Vice President and Chief Information Officer | Profile |
As a trusted advisor to healthcare organizations, Hayes leverages its decades of experience and real world expertise to help clients succeed in a disruptive and evolving healthcare market. From streamlining operations to optimizing systems to developing organizational strategy, Hayes consultants deliver customized services that leave each client fully prepared for success.
DMS Health Group is a Fargo, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Havas Health houses Havas Life (formerly known as Euro RSCG Life), Health4brands (H4B), and Havas Lynx, three wholly-owned Health and Communications Networks, and defines policies and processes for the entire group. Its customer-centric approach has the talent, tenacity and technology that companies, brands and people need to thrive in today`s world.
MedcomSoft Inc. (MedcomSoft) is a developer and distributor of software solutions to the healthcare industry in Canada and United States. The Company develops, markets, licenses and supports healthcare software solutions to the office-based or ambulatory
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.